CANTATA: primary analysis of a global, randomized, placebo (Pbo)-controlled, double-blind trial of telaglenastat (CB-839)+ cabozantinib versus Pbo+ cabozantinib in advanced/metastatic renal cell carcinoma (mRCC) patients (pts) who progressed on immune checkpoint inhibitor (ICI) or anti-angiogenic therapies
one patient was unable to receive intravenous ALA and was switched to oral ALA) with hydroxycitrate and low-dose naltrexone (metabolic treatment) was also investigated [143]
[DOI] [PubMed] [Google Scholar] 35.Rinaldo P., Cowan T.M., Matern D
Factors like lifestyle, age, and health conditions can influence how much of certain vitamins and minerals your body actually gets
Thus, a low-meat diet provides less L-carnitine
But some will notice side effects, minor or annoying, yet not dangerous